Latest News

EU QE: Is it the answer?

Mario Draghi, ECB president announced, on the 22nd of January, the €1.1 trillion asset-purchase program, which has sent the euro tumbling against the dollar to its lowest level for a decade. The recently announced QE program has been shrouded in controversy, with many believing that the unconventional monetary policy doesn’t provide an effective solution. Concerns… Read more »

Pfizer Split?

Pedro Yaguez-Bovio Pfizer is the world’s largest drugmaker with sales of nearly $50 billion in 2014. Pfizer’s management is currently changing the structure of the corporation in a move which could have big impacts for investors. Pfizer has long-term issues related to the expiration of patents for profitable drugs such as Celebrex and Lipitor. However… Read more »

Germany’s Green Goals

Matthew Potts Germany’s influence on the international stage is becoming ever more crucial. With current tensions within the Eurozone over the combative stance from the Greeks regarding the Troika’s bailout programme, the German government is poised to determine the fate of the currency. However, just as intriguing, and important, is the nation’s current domestic energy… Read more »

The Big Six pricing strategies under pressure?

Alisa Strokova The industry regulatory body, Ofgem, reports energy suppliers exploiting decreasing wholesale prices of gas as their average pretax profits rise to £114 per household despite the latest trend of price cuts. It suggests the companies have failed to maintain prices respective to falling wholesale prices across the last two years. Ofgem’s supply market… Read more »